| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 920,000 | 901,000 | 911,000 | 1,226,000 | | Cost of Revenue | (442,000) | 591,000 | 428,000 | 558,000 | | | Gross Profit | 1,362,000 | 310,000 | 483,000 | 668,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,165,000 | 135,000 | 294,000 | 372,000 | | Non Recurring | 3,000 | 43,000 | 1,471,000 | 6,000 | | Others | 45,000 | 43,000 | 47,000 | 47,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 149,000 | 89,000 | (1,329,000) | 243,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,000 | 4,000 | 6,000 | 7,000 | | Earnings Before Interest And Taxes | 152,000 | 93,000 | (1,323,000) | 250,000 | | Interest Expense | 26,000 | 19,000 | 21,000 | 22,000 | | Income Before Tax | 126,000 | 74,000 | (1,344,000) | 228,000 | | Income Tax Expense | 55,000 | 29,000 | 12,000 | 86,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 71,000 | 45,000 | (1,356,000) | 142,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 71,000 | 45,000 | (1,356,000) | 142,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $71,000 | $45,000 | ($1,356,000) | $142,000 |
|
2.03% Nasdaq 
Income Statement
